| RERFX | TPYRX | RERFX / TPYRX | |
| Total Expense Ratio | 0.52 | 0.79 | 66% |
| Annual Report Gross Expense Ratio | 0.52 | 1.01 | 51% |
| Fund Existence | 24 years | 3 years | - |
| Gain YTD | 4.100 | -1.852 | -221% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 50000 | 1% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 141B | 91.8M | 153,595% |
| Annual Yield % from dividends | 2.75 | 1.50 | 184% |
| Returns for 1 year | 8.61 | -4.93 | -175% |
| Returns for 3 years | 19.63 | N/A | - |
| Returns for 5 years | -1.92 | N/A | - |
| Returns for 10 years | 48.82 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| ICTTX | 17.54 | 0.25 | +1.45% |
| ICON Health and Information Tech Inv | |||
| KLCKX | 11.61 | 0.14 | +1.22% |
| Federated Hermes Kaufmann Large Cap R | |||
| MAIMX | 27.82 | -0.02 | -0.07% |
| Victory Integrity Mid-Cap Value A | |||
| PRDGX | 89.92 | -0.39 | -0.43% |
| T. Rowe Price Dividend Growth | |||
| MSEGX | 55.92 | -1.21 | -2.12% |
| Morgan Stanley Inst Growth A | |||